President Trump has announced several proposed changes to how Medicare buys certain expensive prescription drugs, relying in part upon a benchmark price index of other developed countries, who negotiate lower prices. But critics wonder why the U.S. government doesn't do the negotiating itself. William Brangham speaks to Secretary of Health and Human Services Alex Azar, who is overseeing the plan.
Stream your PBS favorites with the PBS app: [ Ссылка ]
Find more from PBS NewsHour at [ Ссылка ]
Subscribe to our YouTube channel: [ Ссылка ]
Follow us:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Snapchat: @pbsnews
Subscribe:
PBS NewsHour podcasts: [ Ссылка ]
Newsletters: [ Ссылка ]
